share repurchase

Latest news articles about share repurchase

Empery Digital Announces Update on Share Repurchase Program

EMPD

(NASDAQ:EMPD) AUSTIN, Texas--(BUSINESS WIRE)---- $EMPD #BTC--Empery Digital Inc. (NASDAQ: EMPD) (the “Company” or “Empery Digital”) today announced an update on its previously authorized share repurchase program. As of September 5, 2025, the Company has repurchased 1,626,007 shares of its common stock under its $100 million share repurchase program, at an average purchase price per share of $7.23, including all fees and commissions. This represents the maximum number of shares permitted to be repurchased in the open market

September 8, 2025Read more →

International Petroleum Corporation Announces Results of Normal Course Issuer Bid and Updated Share Capital

IPCO

(IPCO) TORONTO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 289,393 IPC common shares (ISIN: CA46016U1084) during the period of August 25 to 29, 2025 under IPC’s normal course issuer bid / share repurchase program (NCIB).

August 29, 2025Read more →

BUTLER NATIONAL CORPORATION REPURCHASES 2.41 MILLION SHARES

BUKS

Corporation Establishes New Stock Repurchase Program and Closes 2016 Program NEW CENTURY, Kan., Aug. 13, 2025 /PRNewswire/ -- Butler National Corporation (OTCQX: BUKS), a leader in the growing global market for aircraft modification, maintenance, repair and overhaul and a recognized...

August 13, 2025Read more →

WASTE CONNECTIONS RENEWS NORMAL COURSE ISSUER BID FOR SHARE REPURCHASES

WCN

TORONTO, Aug. 8, 2025 /PRNewswire/ -- Waste Connections, Inc. (TSX/NYSE: WCN) ("Waste Connections" or the "Company") today announced that it has received approval from the Toronto Stock Exchange (the "TSX") for the annual renewal of its normal course issuer bid (the "NCIB"). The renewal...

August 8, 2025Read more →

BioRestorative Announces Share Repurchase Program

BRTX

MELVILLE, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced that its Board of Directors has authorized a stock repurchase program under which the Company may repurchase up to $2 million of its outstanding common stock through June 16, 2026.

June 17, 2025Read more →